Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (271-280 of 333) with videos related to

Pageof 34
Sort By:
Cancer Discovery|October 10, 2020
Precision Prevention and Cancer Interception: The New Challenges of Liquid BiopsyMaria Jose Serrano, Maria Carmen Garrido-Navas, Juan Jose Diaz Mochon, et al.
The Oncologist|September 9, 2021
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic MalignanciesOscar Arrieta, Luis Lara-Mejía, Elysse Bautista-GonzÁlez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2025
Safety, Tolerability, and Immunogenicity of Revaccination with mRNA-1345, an mRNA Vaccine Against RSV, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 YearsJaya Goswami, Jose F Cardona, Jorge Caso, et al.
JAMA Oncology|September 6, 2019
Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical TrialOscar Arrieta, Feliciano Barrón, Miguel-Ángel Salinas Padilla, et al.
JCO Global Oncology|May 30, 2020
Mortality and Advanced Support Requirement for Patients With Cancer With COVID-19: A Mathematical Dynamic Model for Latin AmericaAlejandro Ruiz-Patiño, Oscar Arrieta, Luis E Pino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2014
Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancerMiguel A Molina-Vila, Jordi Bertran-Alamillo, Amaya Gascó, et al.
Oncology|March 7, 2018
Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology PracticesClaudio Martín, Andrés F Cardona, Zyanya Lucia Zatarain-Barrón, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical TrialOscar Arrieta, Norma Hernández-Pedro, Federico Maldonado, et al.
Lancet Regional Health. Americas|December 1, 2025
Corrigendum to "Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study"- the Lancet Regional Health-Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172Andrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativ, et al.
Translational Lung Cancer Research|October 24, 2025
Molecular and clonal evolution of primary lesions <i>vs.</i> brain metastasis in <i>EGFR</i>-mutated NSCLC: a retrospective cohort studyAlejandro Ruíz-Patiño, Jairo Zuluaga, Nicolle Wagner-Gutierrez, et al.
Pageof 34

Showing results (271-280 of 333) with videos related to

Sort By:
Pageof 34
Cancer Discovery|October 10, 2020
Precision Prevention and Cancer Interception: The New Challenges of Liquid BiopsyMaria Jose Serrano, Maria Carmen Garrido-Navas, Juan Jose Diaz Mochon, et al.
The Oncologist|September 9, 2021
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic MalignanciesOscar Arrieta, Luis Lara-Mejía, Elysse Bautista-GonzÁlez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2025
Safety, Tolerability, and Immunogenicity of Revaccination with mRNA-1345, an mRNA Vaccine Against RSV, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 YearsJaya Goswami, Jose F Cardona, Jorge Caso, et al.
JAMA Oncology|September 6, 2019
Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical TrialOscar Arrieta, Feliciano Barrón, Miguel-Ángel Salinas Padilla, et al.
JCO Global Oncology|May 30, 2020
Mortality and Advanced Support Requirement for Patients With Cancer With COVID-19: A Mathematical Dynamic Model for Latin AmericaAlejandro Ruiz-Patiño, Oscar Arrieta, Luis E Pino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2014
Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancerMiguel A Molina-Vila, Jordi Bertran-Alamillo, Amaya Gascó, et al.
Oncology|March 7, 2018
Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology PracticesClaudio Martín, Andrés F Cardona, Zyanya Lucia Zatarain-Barrón, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical TrialOscar Arrieta, Norma Hernández-Pedro, Federico Maldonado, et al.
Lancet Regional Health. Americas|December 1, 2025
Corrigendum to "Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study"- the Lancet Regional Health-Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172Andrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativ, et al.
Translational Lung Cancer Research|October 24, 2025
Molecular and clonal evolution of primary lesions <i>vs.</i> brain metastasis in <i>EGFR</i>-mutated NSCLC: a retrospective cohort studyAlejandro Ruíz-Patiño, Jairo Zuluaga, Nicolle Wagner-Gutierrez, et al.
Pageof 34